Journal
ACS CENTRAL SCIENCE
Volume 6, Issue 4, Pages 546-554Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.9b01268
Keywords
-
Categories
Funding
- Fonds der Chemischen Industrie through a Liebig Fellowship
- TUM Junior Fellow Fund
Ask authors/readers for more resources
Covalent inhibitors have recently seen a resurgence of interest in drug development. Nevertheless, compounds, which do not rely on an enzymatic activity, have almost exclusively been developed to target cysteines. Expanding the scope to other amino acids would be largely facilitated by the ability to globally monitor their engagement by covalent inhibitors. Here, we present the use of light-activatable 2,5-disubstituted tetrazoles that allow quantifying 8971 aspartates and glutamates in the bacterial proteome with excellent selectivity. Using these probes, we competitively map the binding sites of two isoxazolium salts and introduce hydrazonyl chlorides as a new class of carboxylic-acid-directed covalent protein ligands. As the probes are unreactive prior to activation, they allow global profiling even in living Gram-positive and Gram-negative bacteria. Taken together, this method to monitor aspartates and glutamates proteome-wide will lay the foundation covalent inhibitors targeting these amino acids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available